|
1
|
Anderson CD, Pinson CW, Berlin J and Chari
RS: Diagnosis and treatment of cholangiocarcinoma. Oncologist.
9:43–57. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tyson GL and El-Serag HB: Risk factors for
cholangiocarcinoma. Hepatology. 54:173–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
IARC. A Review of Human Carcinogens:
Opisthorchis viverrini and Clonorchis sinensis. IARC Monogr Eval
Carcinog Risks Hum. 100B:341–370. 2012.
|
|
4
|
Gerl R and Vaux DL: Apoptosis in the
development and treatment of cancer. Carcinogenesis. 26:263–270.
2005. View Article : Google Scholar
|
|
5
|
Kaufmann SH and Earnshaw WC: Induction of
apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hannun YA: Apoptosis and the dilemma of
cancer chemotherapy. Blood. 89:1845–1853. 1997.PubMed/NCBI
|
|
7
|
Hail N Jr and Lotan R: Cancer
chemoprevention and mitochondria: targeting apoptosis in
transformed cells via the disruption of mitochondrial
bioenergetics/redox state. Mol Nutr Food Res. 53:49–67. 2009.
View Article : Google Scholar
|
|
8
|
Turrens JF: Mitochondrial formation of
reactive oxygen species. J Physiol. 552:335–344. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Desagher S and Martinou JC: Mitochondria
as the central control point of apoptosis. Trends Cell Biol.
10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasibhatla S and Tseng B: Why target
apoptosis in cancer treatment? Mol Cancer Ther. 2:573–580.
2003.PubMed/NCBI
|
|
12
|
Zhang HM and Zhang Y: Melatonin: a
well-documented anti-oxidant with conditional pro-oxidant actions.
J Pineal Res. 57:131–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartsch C, Bartsch H and Karasek M:
Melatonin in clinical oncology. Neuro Endocrinol Lett. 23:30–38.
2002.PubMed/NCBI
|
|
14
|
Jung B and Ahmad N: Melatonin in cancer
management: progress and promise. Cancer Res. 66:9789–9793. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laothong U, Pinlaor P, Boonsiri P, et al:
Melatonin inhibits cholangiocarcinoma and reduces liver injury in
Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated
hamsters. J Pineal Res. 55:257–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sripa B, Leungwattanawanit S, Nitta T, et
al: Establishment and characterization of an
opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).
World J Gastroenterol. 11:3392–3397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanchez-Barcelo EJ, Cos S, Fernandez R and
Mediavilla MD: Melatonin and mammary cancer: a short review. Endocr
Relat Cancer. 10:153–159. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hill SM, Frasch T, Xiang S, Yuan L,
Duplessis T and Mao L: Molecular mechanisms of melatonin anticancer
effects. Integr Cancer Ther. 8:337–346. 2009. View Article : Google Scholar
|
|
19
|
Barrenetxe J, Delagrange P and Martinez
JA: Physiological and metabolic functions of melatonin. J Physiol
Biochem. 60:61–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bejarano I, Espino J, Barriga C, Reiter
RJ, Pariente JA and Rodriguez AB: Pro-oxidant effect of melatonin
in tumour leucocytes: relation with its cytotoxic and pro-apoptotic
effects. Basic Clin Pharmacol Toxicol. 108:14–20. 2011. View Article : Google Scholar
|
|
21
|
Rodriguez C, Martin V, Herrera F, et al:
Mechanisms involved in the pro-apoptotic effect of melatonin in
cancer cells. Int J Mol Sci. 14:6597–6613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carbajo-Pescador S, Garcia-Palomo A,
Martin-Renedo J, Piva M, Gonzalez-Gallego J and Mauriz JL:
Melatonin modulation of intracellular signaling pathways in
hepatocarcinoma HepG2 cell line: role of the MT1 receptor. J Pineal
Res. 51:463–471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han Y, Demorrow S, Invernizzi P, et al:
Melatonin exerts by an autocrine loop antiproliferative effects in
cholangiocarcinoma: its synthesis is reduced favoring
cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol.
301:G623–G633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Motilva V, Garcia-Maurino S, Talero E and
Illanes M: New paradigms in chronic intestinal inflammation and
colon cancer: role of melatonin. J Pineal Res. 51:44–60. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Proietti S, Cucina A, Reiter RJ and
Bizzarri M: Molecular mechanisms of melatonin’s inhibitory actions
on breast cancers. Cell Mol Life Sci. 70:2139–2157. 2013.
View Article : Google Scholar
|
|
26
|
Laothong U, Pinlaor P, Hiraku Y, et al:
Protective effect of melatonin against Opisthorchis
viverrini-induced oxidative and nitrosative DNA damage and liver
injury in hamsters. J Pineal Res. 49:271–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buyukavci M, Ozdemir O, Buck S, Stout M,
Ravindranath Y and Savasan S: Melatonin cytotoxicity in human
leukemia cells: relation with its pro-oxidant effect. Fundam Clin
Pharmacol. 20:73–79. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bejarano I, Espino J, Marchena AM, et al:
Melatonin enhances hydrogen peroxide-induced apoptosis in human
promyelocytic leukaemia HL-60 cells. Mol Cell Biochem. 353:167–176.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lissoni P, Paolorossi F, Tancini G, et al:
A phase II study of tamoxifen plus melatonin in metastatic solid
tumour patients. Br J Cancer. 74:1466–1468. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martin-Renedo J, Mauriz JL, Jorquera F,
Ruiz-Andres O, Gonzalez P and Gonzalez-Gallego J: Melatonin induces
cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line.
J Pineal Res. 45:532–540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Osseni RA, Rat P, Bogdan A, Warnet JM and
Touitou Y: Evidence of prooxidant and antioxidant action of
melatonin on human liver cell line HepG2. Life Sci. 68:387–399.
2000. View Article : Google Scholar
|
|
32
|
Kim W, Jeong JW and Kim JE: CCAR2
deficiency augments genotoxic stress-induced apoptosis in the
presence of melatonin in non-small cell lung cancer cells. Tumour
Biol. 135:10919–10929. 2014. View Article : Google Scholar
|
